000			03839nam a22004935i 4500
999			_c10692 _d10692
001			10692
003			ES-VaUE
005			20210614143005.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210308s2021 gw | o |||| 0|eng d
020			_a3030652254
024	7		_a10.1007/978-3-030-65225-8 _2doi
040			_bspa _dES-VaUE
050			_aRD661 _b.R66 2021 EB
072		7	_aMMKL _2bicssc
072		7	_aMED015000 _2bisacsh
072		7	_aMKPL _2thema
082	0	4	_a616.028 _223
100	1		_aRommes, Hans., _eauthor _4aut _4http://id.loc.gov/vocabulary/relators/aut
245	1	0	_aSelective Decontamination of the Digestive Tract (SDD) _bCurrent Guidelines _cby Hans Rommes, Rick van Saene, Miguel A. de la Cal
250			_a1st ed. 2021
264		1	_aCham _bSpringer Nature _c2021
300			_a1 online resource (XXXI, 289 p. 45 illus., 18 illus. in color.)
336			_atext _btxt [ _2rdacontent]
337			_acomputer _bc [ _2rdamedia]
338			_aonline resource _bcr [ _2rdacarrier]
505	0		_aPart I. The basics -- Introduction -- Microorganisms -- Defense -- Infections -- Infection control -- Enteral and parenteral antimicrobials used in the SDD-policy -- Part II. Clinical microbiology for the ICU team -- Clinical microbiology: an overview -- Surveillance versus diagnostic cultures -- Sampling and microscopy -- Inoculation and culturing -- Naming of microorganisms -- Antibiotic sensitivity testing -- Availability of the clinical microbiological results for the intensivist -- Part III. Therapeutics -- Therapy of bacterial and fungal infections -- Viral infections in the ICU -- Inflammation and hyperinflammation -- Part IV. Surveillance -- Resistance -- Outbreaks -- Appendix -- Appendix 1. General principles before implementing the SDD-strategy -- Appendix 2. Selective decontamination of the digestive tract -- Appendix 3. SDD in Methicillin-resistant S. aureus (MRSA) -- Appendix 4. SDD in Multidrug-resistant Gram-negative bacteria (MDRGNB)
520			_aThis book explains the basic concepts of Selective Decontamination of the Digestive tract (SDD) to help those involved in treating critically ill patients to improve outcomes and the quality of care. SDD has led to major changes in our understanding, the treatment and prevention of infections in critically ill patients over the past 40 years. It is the most studied intervention in intensive care medicine and is the subject of 73 randomized controlled trials, including over 15000 patients and 15 meta-analyses. SDD reduces morbidity and mortality, is cost-effective and safe as SDD does not increase antimicrobial resistance. Correct application of the SDD strategy enables ICU teams to control infections even in ICUs with endemic antibiotic resistant microorganisms such as methicillin resistant S. aureus (MRSA). Describing the concept and application of SDD, and presenting case studies and microbiological flow charts, this practical guide will appeal to intensivists, critical care practitioners, junior doctors, microbiologists and ICU-nurses as well as infection control specialists and pharmacists. .
650		0	_aCritical care medicine
650		0	_aInternal medicine
650		0	_aNursing
650		0	_aMicrobiology
650	1	4	_aIntensive / Critical Care Medicine.
650	2	4	_aInternal Medicine.
650	2	4	_aNursing.
650	2	4	_aMicrobiology.
700	1		_avan Saene, Rick., _eauthor _4aut _4http://id.loc.gov/vocabulary/relators/aut
700	1		_ade la Cal, Miguel A., _eauthor _4aut _4http://id.loc.gov/vocabulary/relators/aut
776			_z3-030-65224-6
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-65225-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db